PL2416794T3 - Kompozycje na bazie roślin do zapobiegania lub leczenia wirusowych chorób przenoszonych przez krew spowodowanych ludzkim wirusem niedoboru odporności (HIV) lub zapalenia wątroby typu C - Google Patents

Kompozycje na bazie roślin do zapobiegania lub leczenia wirusowych chorób przenoszonych przez krew spowodowanych ludzkim wirusem niedoboru odporności (HIV) lub zapalenia wątroby typu C

Info

Publication number
PL2416794T3
PL2416794T3 PL09784375T PL09784375T PL2416794T3 PL 2416794 T3 PL2416794 T3 PL 2416794T3 PL 09784375 T PL09784375 T PL 09784375T PL 09784375 T PL09784375 T PL 09784375T PL 2416794 T3 PL2416794 T3 PL 2416794T3
Authority
PL
Poland
Prior art keywords
hepatitis
hiv
prevention
plant
treatment
Prior art date
Application number
PL09784375T
Other languages
English (en)
Inventor
Kettany Sleimen El
Original Assignee
El Khatib Nadia
Kettany Sleimen El
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by El Khatib Nadia, Kettany Sleimen El filed Critical El Khatib Nadia
Publication of PL2416794T3 publication Critical patent/PL2416794T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL09784375T 2009-04-10 2009-04-10 Kompozycje na bazie roślin do zapobiegania lub leczenia wirusowych chorób przenoszonych przez krew spowodowanych ludzkim wirusem niedoboru odporności (HIV) lub zapalenia wątroby typu C PL2416794T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR2009/050678 WO2010116048A1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang telles que les maladies causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c
EP09784375.9A EP2416794B1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c

Publications (1)

Publication Number Publication Date
PL2416794T3 true PL2416794T3 (pl) 2014-09-30

Family

ID=41723043

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09784375T PL2416794T3 (pl) 2009-04-10 2009-04-10 Kompozycje na bazie roślin do zapobiegania lub leczenia wirusowych chorób przenoszonych przez krew spowodowanych ludzkim wirusem niedoboru odporności (HIV) lub zapalenia wątroby typu C

Country Status (16)

Country Link
US (1) US20120076849A1 (pl)
EP (1) EP2416794B1 (pl)
JP (1) JP5472445B2 (pl)
CN (1) CN102458432B (pl)
AU (1) AU2009344046B2 (pl)
CA (1) CA2758365A1 (pl)
CY (1) CY1115326T1 (pl)
DK (1) DK2416794T3 (pl)
ES (1) ES2452482T3 (pl)
HR (1) HRP20140230T8 (pl)
PL (1) PL2416794T3 (pl)
PT (1) PT2416794E (pl)
RS (1) RS53216B (pl)
RU (1) RU2543319C2 (pl)
SI (1) SI2416794T1 (pl)
WO (1) WO2010116048A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2973249B1 (fr) * 2011-03-28 2014-02-07 Centre Nat Rech Scient Utilisation de l'epigallocatechine gallate comme agent antiviral contre les infections par le virus de l'hepatite c
KR101899122B1 (ko) * 2017-04-20 2018-09-21 주식회사 제넨셀 C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
WO2021226037A1 (en) * 2020-05-04 2021-11-11 Sulfagenix, Inc. Treatment of viral infections

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202932A (en) * 1878-04-30 Improvement in hog-cholera compounds
FR2296426A1 (fr) * 1975-01-03 1976-07-30 Durupt Marie Helene Elixir
US4692342A (en) * 1985-11-14 1987-09-08 Nabisco Brands, Inc. Process for honey-roasting nuts
JPH0683635B2 (ja) * 1986-03-28 1994-10-26 株式会社ロツテ 抗菌作用の増強されたかりんエキスを配合した菓子類
FR2619716B1 (fr) * 1987-08-26 1991-02-08 Letourneur Bernard Medicament et produit veterinaire pour le traitement de la sterilite
FR2622800B1 (fr) * 1987-11-05 1990-03-23 Hauser Denis Procede de preparation d'un produit de lutte contre des affections virales en particulier des affections virales cutaneo-muqueuses,compositions pharmaceutiques et medicaments obtenus a partir de ce procede
JPH02270824A (ja) * 1989-04-13 1990-11-05 Snow Brand Milk Prod Co Ltd 逆転写酵素阻害剤
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
WO1994018957A2 (de) * 1993-02-26 1994-09-01 Ina Levi Behandlung von (retro)viralen erkrankungen sowie verfahren zur herstellung einer pharmazeutischen zubereitung
CN1300623A (zh) * 1999-12-20 2001-06-27 张发平 一种中成药
US6641801B1 (en) * 2000-04-03 2003-11-04 Love Lives Gargle method to reduce the duration of common cold symptoms
US6841174B2 (en) * 2000-09-20 2005-01-11 Zeyad Technologies Llc Herbal compositions and treatment methods
WO2002096405A1 (en) * 2001-05-25 2002-12-05 Ssp Co., Ltd. Drug preparations
GEP20032886B (en) * 2001-08-22 2003-02-25 Maka Burdiladze Plant Species for Treatment of Chronic Hepatite
KR20010099494A (ko) * 2001-10-09 2001-11-09 이영성, 권두한 큰등골짚신나물로부터 분리한 ｂ형 간염바이러스 표면항원억제물질과 그 추출방법 및 용도
AU2003237060A1 (en) * 2002-06-29 2004-01-19 Biokorea Co., Ltd (e)-1-(((2e, 4e)-1-hexyl-2,4-octadecadienyl)oxy)-2-hydroxydiazine and a pharmaceutical composition for treating hepatitis
JP2004161623A (ja) * 2002-11-11 2004-06-10 Noevir Co Ltd 水性スティック状抗アクネ用組成物
DE202005007603U1 (de) * 2005-05-13 2005-08-04 HD Health Development GmbH Zusammensetzung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl
FR2901699A1 (fr) * 2006-06-06 2007-12-07 Christian Maret Compositions dont les proprietes sont dues a l'association d'elements synergises, leur procede de preparation et leurs utilisations en cosmetique ou hygiene

Also Published As

Publication number Publication date
HRP20140230T8 (hr) 2015-12-04
JP5472445B2 (ja) 2014-04-16
CY1115326T1 (el) 2017-01-04
SI2416794T1 (sl) 2014-05-30
DK2416794T3 (en) 2014-03-17
RU2543319C2 (ru) 2015-02-27
AU2009344046B2 (en) 2014-10-30
WO2010116048A1 (fr) 2010-10-14
CN102458432B (zh) 2015-04-22
RU2011143088A (ru) 2013-05-10
ES2452482T3 (es) 2014-04-01
AU2009344046A1 (en) 2011-11-10
CA2758365A1 (fr) 2010-10-14
CN102458432A (zh) 2012-05-16
RS53216B (sr) 2014-08-29
EP2416794B1 (fr) 2013-12-25
EP2416794A1 (fr) 2012-02-15
WO2010116048A8 (fr) 2011-11-10
HRP20140230T1 (hr) 2014-05-09
JP2012523396A (ja) 2012-10-04
US20120076849A1 (en) 2012-03-29
PT2416794E (pt) 2014-03-17

Similar Documents

Publication Publication Date Title
MX346264B (es) Compuestos antivirales.
MX2020002151A (es) Compuestos antivirales.
CY1123324T1 (el) Παραγωγα πυριμιδινης για τη θεραπευτικη αντιμετωπιση ιογενων λοιμωξεων
PL3542817T3 (pl) Przeciwciała neutralizujące ludzki wirus niedoboru odporności (hiv)
EP2429993A4 (en) HEMMER OF THE REPRODUCTION OF HUMAN IMMUNE DEFICIENCY VIRUSES
ECSP13010937A (es) Compuestos antivirales
PL3556396T3 (pl) Przeciwciała neutralizujące ludzki wirus niedoboru odporności (hiv)
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
CL2015000482A1 (es) Compuestos derivado de 6-aminoacido-heteriarildihidropirimidinas; proceso de obtención; composicion farmaceutica; y su uso para el tratamiento o profilaxis de la infección por el virus de la hepatitis b
ATE541841T1 (de) Inhibitoren der replikation des human immunodeficiency virus
EP2152261A4 (en) TREATMENT OF VIRAL RELATED LESIONS
PH12015501156A1 (en) Pharmaceutical compositions
WO2011150190A3 (en) Hcv inhibitor compounds and methods of use thereof
JO3281B1 (ar) مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
IL232393A0 (en) Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
FR2969926B1 (fr) Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
BR112014015582A2 (pt) compostos antivirais
PL2416794T3 (pl) Kompozycje na bazie roślin do zapobiegania lub leczenia wirusowych chorób przenoszonych przez krew spowodowanych ludzkim wirusem niedoboru odporności (HIV) lub zapalenia wątroby typu C
GB2463584A (en) Carbohydrate-lipid constructs and their use in preventing or treating viral infection
PH12013500558A1 (en) Solid state forms of a potent hcv inhibitor
GB2470494B (en) Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
EP2160191A4 (en) SUPPRESSION OF VIRUSES INVOLVED IN A DISEASE OR RESPIRATORY INFECTION
TN2013000135A1 (en) Solid state forms of a potent hcv inhibitor
TH148307A (th) การรักษาการติดเชื้อไวรัสตับอักเสบ c โดยใช้อะลิสพอริเวียร์